Retro-peritoneal cystic lymphangioma in association with fetal hydantoin syndrome

Indian Journal of Pediatrics

Volumn 66, Issue 2, 1999, Pages 294-297

  Khetarpal, Rajan ^a   Halwai, Ghanshyam ^a   Marwaha, R K ^a   Trehan, Amita ^a   Narasimhan, K L ^a   Bhalla, A K ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Fetal hydantoin syndrome; Retroperitoneal lymphangioma

Indexed keywords

ANTICONVULSIVE AGENT; PHENYTOIN;

ARTICLE; CASE REPORT; CHEMICALLY INDUCED DISORDER; CONGENITAL MALFORMATION; CYSTIC LYMPHANGIOMA; DEVELOPMENTAL DISORDER; FEMALE; HUMAN; INFANT; MALE; RETROPERITONEAL TUMOR; SYNDROME;

ABNORMALITIES, DRUG-INDUCED; ANTICONVULSANTS; DEVELOPMENTAL DISABILITIES; FEMALE; HUMANS; INFANT; LYMPHANGIOMA, CYSTIC; MALE; PHENYTOIN; RETROPERITONEAL NEOPLASMS; SYNDROME;

EID: 0033085883     PISSN: 00195456     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02761223     Document Type: Article

References (19)

1. McNamara JO. Drugs effective in the therapy of the epilepsies. In: Hardman JG, Limbird LE, (eds). Goodman and Gilman's The Pharmacological Basis of Therapeutics. New York : Mc Graw Hill, 1996 : 461-486.
2. Hanson JW, Smith DW. The fetal hydantoin syndrome. J Pediat 1975; 87(2) : 285-290.
3. Jones KL. Environmental agents : fetal hydantoin effects. In : Smith's Recognizable Patterns of Human Malformations. Philadephia : WB Sanuders Co, 1993 : 495.
4. Nanake Y, Okuma T, Takahashi R et al. Multi-institutional study on the teratogenicity and fetal toxicity of antiepileptic drugs : a report of a collaborative study group in Japan. Epilepsia 1980; 21 (6) : 663-680.
5. Fedrick J. Epilepsy and pregnancy : a report from the Oxford Record Linkage study. Br Med J 1973; 2 : 442-448.
6. Stickler SM, Dansky LV, Miller MA, Seni MH Andermann E, Spielberg SP. Genetic predisposition to phenytoin induced birth defects. Lancet 1985; 2 : 746-749.
7. Raymonds GV, Buehler BA, Finnell RH, Holmes LB. Anticonvulsant teratogenesis : 3 possible metabolic basis. Teratology 1995; 51: 55-56.
8. Buehler BA, Delimont D, van Wess M, Finnell RH. Prenatal prediction of the risk of the fetal hydantoin syndrome. New Engl J Med 1990; 322 : 1567-1572.
9. Buehler BA, Bick D, Delimont D. Prenatal prediction of the risk of the fetal hydantoin syndrome. New Engl J Med 1993; 329 : 1660-1661.
10. Roisman I, Manny J, Fields S, Shiloni E. Intra-abdominal lymphagiomas. Br J Surg 1989; 76 : 485-489.
11. Henzel JT,. Pories WJ, Burget DE, Smith JL Intra-abdominal lymphangiomata. Arach Surg 1966; 93 : 304-308.
12. Ros PR, Olmsted WW, Moser RP, Dachman AH, Hjermstad BH, Sobin LH. Mesenteric and omental cysts : histological classification with imaging correlation. Radiology 1987; 164 : 327-332.
13. Carpenter HA, Lancaster JR, Lee RA. Multilocular cysts of the peritoneum. Mayo Clin Proc 1982; 57 : 634-638.
14. Murray JC, Hill RM, Hegernier S, Hurwitz RL. Lymphoblastic lymphoma following prenatal exposure to phenytoin. J Pediatr Hematol Oncol 1996; 18 (2) : 241-243.
15. Abbnodanzo SL, Irey NS, Frizzera G. Dilantin associated lymphadenopathy-spectrum of histopathologic patterns. Am J Surg Pathol 1995; 19 (6) : 675-686.
16. Jeng YM, Tien HF, Su IJ. Phenytoin induced pseudolymphoma : re-evaluation using modern molecular biology techniques. Epilepsia 1996; 37 (1) : 104-107.
17. Nishikawa S, Nagata T, Morisaki I, Oka T, Ishida H. Pathogenesis of drug induced gingival overgrowth. A review of studies in the rat model. J Periodontol 1996; 67 (5): 463-471.
18. van Dyke DC, Hodge SE, Heide F, Hill LR. Family studies in fetal hydantoin exposure. J Pediatr 1988; 113 : 301-306.
19. Kaneko S, Otani K, Fukushima Y et al. Teratogenicity of antiepileptic drugs : analysis of patient risk factors. Epilepsia 1988; 29 (4) : 459-467.